Jones R - Search Results

1

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV.

Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Phillips AN, Sabin CA, Post FA; UK CHIC Study. Jose S, et al. Among authors: jones r. J Infect Dis. 2018 Oct 20;218(11):1767-1772. doi: 10.1093/infdis/jiy397. J Infect Dis. 2018. PMID: 29982487 Free PMC article.

2

Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study.

Jones R, Stebbing J, Nelson M, Moyle G, Bower M, Mandalia S, Gazzard B. Jones R, et al. J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1489-95. doi: 10.1097/01.qai.0000138983.45235.02. J Acquir Immune Defic Syndr. 2004. PMID: 15602127

3

A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study).

Orkin C, Stebbing J, Nelson M, Bower M, Johnson M, Mandalia S, Jones R, Moyle G, Fisher M, Gazzard B. Orkin C, et al. Among authors: jones r. J Antimicrob Chemother. 2005 Feb;55(2):246-51. doi: 10.1093/jac/dkh515. Epub 2004 Dec 17. J Antimicrob Chemother. 2005. PMID: 15608053 Clinical Trial.

4

Preventing HIV infection.

Jones R, Gazzard B, Halima Y. Jones R, et al. BMJ. 2005 Dec 3;331(7528):1285-6. doi: 10.1136/bmj.331.7528.1285. BMJ. 2005. PMID: 16321996 Free PMC article. No abstract available.

5

HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.

Jones R, Gazzard B. Jones R, et al. Expert Rev Anti Infect Ther. 2006 Apr;4(2):303-12. doi: 10.1586/14787210.4.2.303. Expert Rev Anti Infect Ther. 2006. PMID: 16597210 Review.

6

The cost of antiretroviral drugs and influence on prescribing policies.

Jones R, Gazzard B. Jones R, et al. Int J STD AIDS. 2006 Aug;17(8):499-506. doi: 10.1258/095646206778145587. Int J STD AIDS. 2006. PMID: 16925892 Review.

7

Virological failure and subsequent resistance profiles in individuals exposed to atazanavir.

Stebbing J, Nathan B, Jones R, McKenna A, Powles T, Bower M, Holmes P, Gazzard B, Nelson M. Stebbing J, et al. Among authors: jones r. AIDS. 2007 Aug 20;21(13):1826-8. doi: 10.1097/QAD.0b013e3282742000. AIDS. 2007. PMID: 17690587

8

The role of receptors in the HIV-1 entry process.

Jones R, Nelson M. Jones R, et al. Eur J Med Res. 2007 Oct 15;12(9):391-6. Eur J Med Res. 2007. PMID: 17933719 Review.

9

Clinical epidemiology of HIV-associated end-stage renal failure in the UK.

Bansi L, Hughes A, Bhagani S, Mackie NE, Leen C, Levy J, Edwards S, Connolly J, Holt SG, Hendry BM, Sabin C, Post FA; UK CHIC/ESRF study group. Bansi L, et al. AIDS. 2009 Nov 27;23(18):2517-21. doi: 10.1097/QAD.0b013e3283320e12. AIDS. 2009. PMID: 19752713

10

Re-emergent hepatitis C viremia after apparent clearance in HIV-positive men who have sex with men: reinfection or late recurrence?

Jones R, Brown D, Nelson M, Low E, Bhagani S, Atkins M, Danta M, Dusheiko G, Pybus O, Asboe D. Jones R, et al. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):547-50. doi: 10.1097/QAI.0b013e3181ba41e2. J Acquir Immune Defic Syndr. 2010. PMID: 20220378 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,136 results

Search Page

Filters